InvestLog
CELG-RI logo

CELG-RI

Bristol-Myers Squibb Company CeNYSEHealthcare
$0.12+34.76%OpenMarket Cap: $243.2M

As of 2026-04-06

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$12.50B$1.09B$0.53
FY 2025$48.19B$7.05B$3.46
Q3 2025$12.22B$2.20B$1.08
Q2 2025$12.27B$1.31B$0.64

Company Info

Sector

Healthcare

Industry

—

Country

US

Exchange

NYSE

Beta

-0.51

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.